SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001144204-17-048372
Filing Date
2017-09-18
Accepted
2017-09-18 06:14:36
Documents
1
Period of Report
2017-09-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v475336_4a.html 4/A  
1 OWNERSHIP DOCUMENT v475336_4a.xml 4/A 4366
  Complete submission text file 0001144204-17-048372.txt   5836
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O PROTINE DESIGN LAB 37481 MARSTEN DR NEWARK CA 94560
Business Address
SHAH JAISIM (Reporting) CIK: 0001242133 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36150 | Film No.: 171088946